New treatments for age-related macular degeneration.

0Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

As the estimated life expectancy of the U.S. population increases, so will the incidence of age-related macular degeneration (AMD). Exudative (or "wet") AMD, which is characterized by choroidal neovascularization, carries a high risk of extreme central vision loss and can severely compromise an individual's independence and quality of life. The increasing burden of AMD has created an acute need for more effective treatments. During the last several years, treatment of exudative AMD with intravitreal injection of antivascular endothelial growth factor (anti-VEGF) has dramatically reduced the severe visual loss usually associated with this disorder. This article summarizes the clinical presentation of AMD and reviews the treatments that are currently available.

Cite

CITATION STYLE

APA

Mittra, R. A., & Ramsay, R. C. (2009). New treatments for age-related macular degeneration. Minnesota Medicine, 92(6), 41–44. https://doi.org/10.17925/eor.2010.04.01.92

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free